Literature DB >> 30028259

Clinical characteristics of lupus enteritis in Japanese patients: the large intestine-dominant type has features of intestinal pseudo-obstruction.

A Maruyama1, T Nagashima1, M Iwamoto1, S Minota1.   

Abstract

This study was performed to investigate the clinical characteristics of lupus enteritis in Japanese patients with systemic lupus erythematosus (SLE). A total of 481 patients with SLE admitted to our hospital between 2001 and 2015 were retrospectively reviewed. Diagnosis of lupus enteritis was based on the following three criteria: (1) abdominal symptoms, (2) diffuse long-segment bowel thickening and (3) a requirement for glucocorticoid therapy. Lupus enteritis was identified in 17 patients (3.5%) and there were two distinct types: small intestine-dominant and large intestine-dominant. Significant differences between the two types were noted with respect to the age, frequency of biopsy-proven lupus nephritis, frequency of rectal involvement, maximum bowel wall thickness, and requirement for steroid pulse therapy. Among patients with large intestine-dominant lupus enteritis, 60% had extra-intestinal symptoms (hydroureter, bladder wall thickening, and bile duct dilatation) that are known complications of intestinal pseudo-obstruction. Two patients with large intestine-dominant lupus enteritis developed intestinal pseudo-obstruction either before or after diagnosis of lupus enteritis. Five patients (29%) developed recurrence during a median observation period of 7.2 years (1.4-14.4 years). In conclusion, large intestine-dominant lupus enteritis resembles intestinal pseudo-obstruction and these two diseases may have a common pathogenesis.

Entities:  

Keywords:  Cystitis; hydronephrosis; ileus; mesenteric vasculitis; systemic sclerosis

Mesh:

Substances:

Year:  2018        PMID: 30028259     DOI: 10.1177/0961203318785770

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  3 in total

1.  The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.

Authors:  Tatiana M Reshetnyak; Irina A Doroshkevich; Natalia V Seredavkina; Evgeny L Nasonov; Igor V Maev; Vasiliy I Reshetnyak
Journal:  Int J Rheumatol       Date:  2019-05-05

2.  Intestinal Pseudo-Obstruction as the Initial Clinical Presentation in Systemic Lupus Erythematosus: A Rare and Severe Disorder.

Authors:  Akwe Nyabera; Mohanad Elfishawi; Francisco Cuevas; Fahad Riaz; Adriana Abrudescu
Journal:  Case Rep Gastrointest Med       Date:  2020-11-16

3.  Systemic lupus erythematosus gastrointestinal involvement: a computed tomography-based assessment.

Authors:  Zhiwei Chen; Jiaxin Zhou; Jiaoyu Li; Yiquan Zhou; Xiaodong Wang; Ting Li; Liyang Gu; Fangfang Sun; Wanlong Wu; Wenwen Xu; Shuhui Sun; Jie Chen; Jiajie Li; Liangjing Lu; Wen Zhang; Yan Zhao; Shuang Ye
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.